v3.26.1
Condensed Statements of Cash Flows - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net loss $ (3,622,995) $ (10,482,761)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 129,384 155,349
Amortization 35,697 15,789
Change in fair value of conversion option liability (1,732,413) 0
Change in fair value of warrants liabilities (4,228,000) 0
Amortization of right-of-use assets 232,775 260,819
Loss on fixed asset dispositions 0 53,173
Share-based compensation expense 362,428 549,208
Amortization of debt issuance costs and discount 362,657 746,612
Changes in operating assets and liabilities:    
Accounts receivable 465,551 233,789
Inventory (451,028) (2,186,415)
Prepaid and other assets 308,488 165,056
Accounts payable 499,250 1,758,162
Accrued expenses (184,220) (98,297)
Lease liabilities (249,081) (264,580)
Other liabilities (7,690) (23,854)
Net cash used in operating activities (8,079,197) (9,117,950)
Cash flows from investing activities:    
Acquisition of patents (12,777) (2,733)
Purchases of property and equipment (88,540) (190,834)
Net cash used in investing activities (101,317) (193,567)
Cash flows from financing activities:    
Proceeds from the issuance of common stock in June 2025 financing 0 4,510,001
Issuance costs for June 2025 financing 0 (804,940)
Proceeds from at-the-market sales of common stock 352,922 5,496,791
Issuance costs for at-the-market sales of common stock (10,588) (164,904)
Proceeds from common stock issued through ESPP 15,329 40,875
Net cash provided by financing activities 357,663 9,077,823
Net change in cash and cash equivalents (7,822,851) (233,694)
Cash and cash equivalents:    
Beginning of period 9,266,353 3,451,761
End of period 1,443,502 3,218,067
Cash paid for:    
Income taxes 5,550 6,006
Non-cash investing and financing activities:    
Property and equipment costs included in accounts payable 4,475 83,602
Acquisition of patents included in accounts payable 3,505 2,776
Issuance of warrants for underwriter commission 0 56,035
Payment of November 2023 convertible note interest in common stock 47,841 0
Deferred offering costs reclassified to additional paid-in capital 174 13,283
November 2025 Financing [Member]    
Non-cash investing and financing activities:    
Conversion of convertible notes into common stock 76,452 0
November 2023 Financing [Member]    
Non-cash investing and financing activities:    
Conversion of convertible notes into common stock $ 0 $ 85,000